Connecting Ideas to Therapies at AstraZeneca – Virtual

Open innovation is at the heart of AstraZeneca’s mission to accelerate scientific discovery and turn breakthrough ideas into meaningful patient impact. By connecting academic researchers and institutional partners with their global R&D teams, AstraZeneca creates collaborations that advance novel platforms, cutting-edge technologies, and transformative therapeutic strategies.

In this webinar, AstraZeneca will introduce the scope of their Open Innovation program, highlight the types of opportunities available for collaboration, and share collaboration priorities from their Drug Delivery Innovation team, demonstrating how external science can directly shape the company’s pipeline.

The collaborative research themes covered in this webinar include:

• Nanoparticle Engineering – Partnering on site-specific conjugation methods for diverse ligands as well as orthogonal coupling for multi-ligand functionalization and controlled ligand density & spatial distribution.
• High-Throughput Characterization – Collaborating on advanced analytical tools to quantify ligand density and distribution and integrate stability and biorelevant testing; use modelling to predict stability and understand IVIV correlation. This could include automation approaches as well.
• Complex Formulation Technologies – Exploring next-generation excipients, nano-particles delivery routes, and controlled release strategies to overcome formulation challenges.

Don’t miss this opportunity to gain an insider’s view of how AstraZeneca leverages Open Innovation to drive collaboration in advanced drug delivery and how you can engage to bring bold, transformative ideas to life.